Retraction Note to: External Qi of Yan Xin Qigong induces G2/M arrest and apoptosis of androgen-independent prostate cancer cells by inhibiting Akt and NF-[InlineMediaObject not available: see fulltext.]B pathways (Molecular and Cellular Biochemistry, (2008), 310, 1-2, (227-234), 10.1007/s11010-007-9684-2);External Qi of Yan Xin Qigong induces G2/M arrest and apoptosis of androgen-independent prostate cancer cells by inhibiting Akt and NF-κB pathways

Molecular and Cellular Biochemistry

Volumn 310, Issue 1-2, 2008, Pages 227-234

  Yan, Xin ^a,b   Shen, Hua ^b   Jiang, Hongjian ^a   Zhang, Chengsheng ^d   Hu, Dan ^c   Wang, Jun ^b   Wu, Xinqi ^c  

^a Chong qing Acad Chin Materia Med   (China)

^b New Medical Science Research Institute   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d MCMASTER UNIVERSITY   (Canada)

Author keywords

Akt; Apoptosis; External Qi of Yan Xin Qigong; G2 M arrest; NF B; Prostate cancer

Indexed keywords

ANDROGEN; CYCLIN B1; EPIDERMAL GROWTH FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN KINASE B; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER GROWTH; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL LINE; CELL SURVIVAL; CHINESE MEDICINE; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; ENZYME ACTIVATION; HUMAN; HUMAN CELL; HUVEC CELL LINE; PERIPHERAL BLOOD MONONUCLEAR CELL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

EID: 39949085067     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-021-04163-9     Document Type: Erratum

References (53)

1. 1. A Jemal RC Tiwari T Muarray A Ghafoor A Samueles E Ward EJ Feuer MJ Thun 2004 Cancer statistics CA Cancer J Clin 54 8 29 14974761 10.3322/canjclin.54.1.8 Jemal A, Tiwari RC, Muarray T, Ghafoor A, Samueles A, Ward E, Feuer EJ, Thun MJ (2004) Cancer statistics. CA Cancer J Clin 54:8–29
2. 2. JT Isaacs 2000 Apoptosis: translating theory to therapy for prostate cancer J Natl Cancer Inst (Bethesda) 92 1367 1369 10.1093/jnci/92.17.1367 1:STN:280:DC%2BD3M%2Fmt1SntQ%3D%3D Isaacs JT (2000) Apoptosis: translating theory to therapy for prostate cancer. J Natl Cancer Inst (Bethesda) 92:1367–1369
3. 3. MB Garnick 1997 Hormonal therapy in the management of prostate cancer: from Huggins to the present Urology 49 3A Suppl 5 15 9123737 10.1016/S0090-4295(97)00163-5 1:STN:280:DyaK2s3js12qtg%3D%3D Garnick MB (1997) Hormonal therapy in the management of prostate cancer: from Huggins to the present. Urology 49(3A Suppl):5–15
4. 4. X Yan H Shen M Zaharia J Wang D Wolf F Li W Cao 2004 Involvement of phosphatidylinositol 3-kinase and insulin-like growth factor-I in YXLST-mediated neuroprotection Brain Res 1006 198 206 15051523 10.1016/j.brainres.2004.01.068 1:CAS:528:DC%2BD2cXisF2iurY%3D Yan X, Shen H, Zaharia M, Wang J, Wolf D, Li F, Cao W (2004) Involvement of phosphatidylinositol 3-kinase and insulin-like growth factor-I in YXLST-mediated neuroprotection. Brain Res 1006:198–206
5. 5. X Yan H Shen H Jiang C Zhang D Hu J Wang X Wu 2006 External Qi of Yan Xin Qigong differentially regulates the Akt and extracellular signal-regulated kinase pathways and is cytotoxic to cancer cells but not to normal cells Int J Biochem Cell Biol 38 2102 2113 16893670 10.1016/j.biocel.2006.06.002 1:CAS:528:DC%2BD28XpvFSju7w%3D Yan X, Shen H, Jiang H, Zhang C, Hu D, Wang J, Wu X (2006) External Qi of Yan Xin Qigong differentially regulates the Akt and extracellular signal-regulated kinase pathways and is cytotoxic to cancer cells but not to normal cells. Int J Biochem Cell Biol 38:2102–2113
6. 6. Z Ming 1988 The new frontiers of modern sciences: an introduction to Yan Xin Qigong Xinhua Press Beijing Ming Z (1988) The new frontiers of modern sciences: an introduction to Yan Xin Qigong. Xinhua Press, Beijing
7. 7. Fong YH (1997) Yan Xin Qigong informative product: Qi nutrition powder. In: International Yan Xin Qigong Association (eds) Yan Xin Qigong Collectanea, vol 6. Les Editions LOTUS Publishers of Canada, Quebec, p 299
8. 8. Wang R, Zhu R (1997) Yan Xin Qigong nutrition powder: report of nine cases. In: International Yan Xin Qigong Association (eds) Yan Xin Qigong Collectanea, vol 1. Les Editions LOTUS Publishers of Canada, Quebec, p 266
9. 9. Zhang ZW, Zhao JX, Zhang XR (1999) Yan Xin Qigong nutrition powder: clinical report. In: International Yan Xin Qigong Association (eds) Yan Xin Qigong Collectanea, vol 1. Les Editions LOTUS Publishers of Canada, Quebec, p 319
10. 10. Z Lu 1997 Scientific Qigong exploration: the wonders and mysteries of Qi Amber Leaf Press Malvern, Pennsylvania Lu Z (1997) Scientific Qigong exploration: the wonders and mysteries of Qi. Amber Leaf Press, Malvern, Pennsylvania
11. 11. X Yan H Lin H Li A Traynor-Kaplan Z Xia F Lu Y Fang M Dao 1999 Structural and property changes in certain materials influenced by the external Qi of Qigong Mater Res Innov 2 349 359 10.1007/s100190050113 1:CAS:528:DyaK1MXjt1Oqt7g%3D Yan X, Lin H, Li H, Traynor-Kaplan A, Xia Z, Lu F, Fang Y, Dao M (1999) Structural and property changes in certain materials influenced by the external Qi of Qigong. Mater Res Innov 2:349–359
12. 12. X Yan F Lu H Jiang X Wu W Cao Z Xia M Dao H Lin 2002 Certain manifestation and effects of external Qi of Yan Xin life science and technology J Sci Explor 16 381 411 Yan X, Lu F, Jiang H, Wu X, Cao W, Xia Z, Dao M, Lin H (2002) Certain manifestation and effects of external Qi of Yan Xin life science and technology. J Sci Explor 16:381–411
13. 13. S Li M Sun Z Dai P Zhang G Meng Z Liu Q Ma Q Zhu Q Wang L Zhang L Shan Y Sun Y Hu Y Chen Y Pang G Wang X Hao A Lu X Fan X Yan 1990 Experimental studies on the feasibility of improving industrial strains with external Qi treatment Nat J 13 791 801 Li S, Sun M, Dai Z, Zhang P, Meng G, Liu Z, Ma Q, Zhu Q, Wang Q, Zhang L, Shan L, Sun Y, Hu Y, Chen Y, Pang Y, Wang G, Hao X, Lu A, Fan X, Yan X (1990) Experimental studies on the feasibility of improving industrial strains with external Qi treatment. Nat J 13:791–801
14. 14. X Yan C Zheng G Zou Z Lu 1988 Observations of the effects of external Qi on the ultraviolet absorption of nucleic acids Nat J 11 647 649 1:CAS:528:DyaL1MXlsFWjuw%3D%3D Yan X, Zheng C, Zou G, Lu Z (1988) Observations of the effects of external Qi on the ultraviolet absorption of nucleic acids. Nat J 11:647–649
15. 15. X Yan ZQ Xia H Shen A Traynor-Kaplan 2002 External Qi of Yan Xin life science and technology can revive or suppress enzyme activity of phosphatidylinositol 3-kinase Bull Sci Tech Soc 22 403 406 10.1177/027046702237270 Yan X, Xia ZQ, Shen H, Traynor-Kaplan A (2002) External Qi of Yan Xin life science and technology can revive or suppress enzyme activity of phosphatidylinositol 3-kinase. Bull Sci Tech Soc 22:403–406
16. 16. X Yan YH Fong G Wolf D Wolf W Cao 2001 Protective effect of XY99–5038 on hydrogen peroxide induced cell death in cultured retinal neurons Life Sci 69 289 299 10.1016/S0024-3205(01)01122-5 Yan X, Fong YH, Wolf G, Wolf D, Cao W (2001) Protective effect of XY99–5038 on hydrogen peroxide induced cell death in cultured retinal neurons. Life Sci 69:289–299
17. 17. SN Malik M Brattain PM Ghosh DA Troyer T Prihoda R Bedolla JI Kreisberg 2002 Immunohistochemical demonstration of phospho-Akt in high Gleason grade prostate cancer Clin Cancer Res 8 1168 1171 11948129 Malik SN, Brattain M, Ghosh PM, Troyer DA, Prihoda T, Bedolla R, Kreisberg JI (2002) Immunohistochemical demonstration of phospho-Akt in high Gleason grade prostate cancer. Clin Cancer Res 8:1168–1171
18. 18. H Murillo H Huang LJ Schmidt DI Smith DJ Tindall 2002 Role of PI3K signaling in survival and progression of LNCaP prostate cancer cells to the androgen refractory state Endocrinology 142 114795 114805 Murillo H, Huang H, Schmidt LJ, Smith DI, Tindall DJ (2002) Role of PI3K signaling in survival and progression of LNCaP prostate cancer cells to the androgen refractory state. Endocrinology 142:114795–114805
19. 19. AV Gasparian YJ Yao D Kowalczyk LA Lyakh A Karseladze TJ Slaga IV Budunova 2002 The role of IKK in constitutive activation of NF-κB transcription factor in prostate carcinoma cells J Cell Sci 115 141 151 11801732 1:CAS:528:DC%2BD38XovVeitA%3D%3D Gasparian AV, Yao YJ, Kowalczyk D, Lyakh LA, Karseladze A, Slaga TJ, Budunova IV (2002) The role of IKK in constitutive activation of NF-κB transcription factor in prostate carcinoma cells. J Cell Sci 115:141–151
20. 20. SD Catz JL Johnson 2003 Bcl-2 in prostate cancer: a minireview Apoptosis 8 29 37 12510149 10.1023/A:1021692801278 1:CAS:528:DC%2BD38XpsFyjurc%3D Catz SD, Johnson JL (2003) Bcl-2 in prostate cancer: a minireview. Apoptosis 8:29–37
21. 21. GV Raj JA Sekula R Guo JF Madden Y Daaka 2004 Lysophosphatidic acid promotes survival of androgen-insensitive prostate cancer PC3 cells via activation of NF-κB Prostate 61 105 113 15305333 10.1002/pros.20083 1:CAS:528:DC%2BD2cXosVKmu7o%3D Raj GV, Sekula JA, Guo R, Madden JF, Daaka Y (2004) Lysophosphatidic acid promotes survival of androgen-insensitive prostate cancer PC3 cells via activation of NF-κB. Prostate 61:105–113
22. 22. PF Lindholm J Bub S Kaul VB Shidham A Kajdacsy-Balla 2000 The role of constitutive NF-κB activity in PC-3 human prostate cancer cell invasive behavior Clin Exp Metastasis 18 471 479 11592304 10.1023/A:1011845725394 1:CAS:528:DC%2BD3MXnslSltrw%3D Lindholm PF, Bub J, Kaul S, Shidham VB, Kajdacsy-Balla A (2000) The role of constitutive NF-κB activity in PC-3 human prostate cancer cell invasive behavior. Clin Exp Metastasis 18:471–479
23. 23. S Erlich P Tal-Or R Liebling R Blum D Karunagaran Y Kloog R Pinkase-Kramarski 2006 Ras inhibition results in growth arrest and death of androgen-dependent and androgen-independent prostate cancer cells Biochem Pharmcol 72 427 436 10.1016/j.bcp.2006.05.007 1:CAS:528:DC%2BD28XntFWkur8%3D Erlich S, Tal-Or P, Liebling R, Blum R, Karunagaran D, Kloog Y, Pinkase-Kramarski R (2006) Ras inhibition results in growth arrest and death of androgen-dependent and androgen-independent prostate cancer cells. Biochem Pharmcol 72:427–436
24. 24. Y Li FH Sarkar 2002 Inhibition of nuclear factor κB activation in PC3 cells by genistein is mediated via Akt signaling pathway Clin Cancer Res 8 2369 2377 12114442 1:CAS:528:DC%2BD38XmtVWhtro%3D Li Y, Sarkar FH (2002) Inhibition of nuclear factor κB activation in PC3 cells by genistein is mediated via Akt signaling pathway. Clin Cancer Res 8:2369–2377
25. 25. S Sinha BC Pal S Jagadeesh PP Banerjee A Bandyopadhaya S Bhattacharya 2006 Mahanine inhibits growth and induces apoptosis in prostate cancer cells through the deactivation of Akt and activation of caspases Prostate 66 1257 1265 16683271 10.1002/pros.20415 1:CAS:528:DC%2BD28XpvVemsrg%3D Sinha S, Pal BC, Jagadeesh S, Banerjee PP, Bandyopadhaya A, Bhattacharya S (2006) Mahanine inhibits growth and induces apoptosis in prostate cancer cells through the deactivation of Akt and activation of caspases. Prostate 66:1257–1265
26. 26. A Yemelyanov A Gasparian P Lindholm L Dang JW Pierce F Kisseljov A Karseladze I Budunova 2006 Effects of IKK inhibitor PS1145 on NF-κB function, proliferation, apoptosis and invasion activity in prostate carcinoma cells Oncogene 25 387 398 16170348 1:CAS:528:DC%2BD28Xlt1egtw%3D%3D Yemelyanov A, Gasparian A, Lindholm P, Dang L, Pierce JW, Kisseljov F, Karseladze A, Budunova I (2006) Effects of IKK inhibitor PS1145 on NF-κB function, proliferation, apoptosis and invasion activity in prostate carcinoma cells. Oncogene 25:387–398
27. 27. L Bonaccorsi S Marchiani M Muratori G Forti E Baldi 2004 Gefitinib (‘IRESSA’, ZD1839) inhibits EGF-induced invasion in prostate cancer cells by suppressing PI3 K/AKT activation J Cancer Res Clin Oncol 130 604 614 15258753 10.1007/s00432-004-0581-8 1:CAS:528:DC%2BD2cXns12nsbw%3D Bonaccorsi L, Marchiani S, Muratori M, Forti G, Baldi E (2004) Gefitinib (‘IRESSA’, ZD1839) inhibits EGF-induced invasion in prostate cancer cells by suppressing PI3 K/AKT activation. J Cancer Res Clin Oncol 130:604–614
28. 28. JT Lee LS Steelman JA McCubrey 2004 Phosphatidylinosital 3-kinase activation leads to multidrug resistance protein-1 expression and subsequent chemoresistance in advanced prostate cancer cells Cancer Res 64 8397 8404 15548710 10.1158/0008-5472.CAN-04-1612 1:CAS:528:DC%2BD2cXpvVGksrk%3D Lee JT, Steelman LS, McCubrey JA (2004) Phosphatidylinosital 3-kinase activation leads to multidrug resistance protein-1 expression and subsequent chemoresistance in advanced prostate cancer cells. Cancer Res 64:8397–8404
29. 29. A Arlt A Gehrz S Muerkoster J Vorndamm ML Kruse UR Folsch H Schafer 2003 Role of NF-κB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death Oncogene 22 3243 3251 12761494 10.1038/sj.onc.1206390 1:CAS:528:DC%2BD3sXjvFaksLw%3D Arlt A, Gehrz A, Muerkoster S, Vorndamm J, Kruse ML, Folsch UR, Schafer H (2003) Role of NF-κB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death. Oncogene 22:3243–3251
30. 30. Y Zhang S Banerjee ZW Wang DJ Marciniak AP Majumdar FH Sarkar 2005 Epidermal growth factor receptor-related protein inhibits cell growth and induces apoptosis of BxPC3 pancreatic cancer cells Cancer Res 65 3877 3882 15867387 10.1158/0008-5472.CAN-04-3654 1:CAS:528:DC%2BD2MXjslGks7c%3D Zhang Y, Banerjee S, Wang ZW, Marciniak DJ, Majumdar AP, Sarkar FH (2005) Epidermal growth factor receptor-related protein inhibits cell growth and induces apoptosis of BxPC3 pancreatic cancer cells. Cancer Res 65:3877–3882
31. 31. HG Kim J Kassis JC Souto T Turner A Wells 1999 EGF receptor signaling in prostate morphogenesis and tumorigenesis Histol Histopathol 14 1175 1182 10506934 1:CAS:528:DyaK1MXmsVGmu7g%3D Kim HG, Kassis J, Souto JC, Turner T, Wells A (1999) EGF receptor signaling in prostate morphogenesis and tumorigenesis. Histol Histopathol 14:1175–1182
32. 32. M Mimeault N Pommery JP Henichart 2003 New advances on prostate carcinogenesis and therapies: involvement of EGF-EGFR transduction system Growth Factors 21 1 14 12795332 10.1080/0897719031000094921 1:CAS:528:DC%2BD3sXjvV2kt7g%3D Mimeault M, Pommery N, Henichart JP (2003) New advances on prostate carcinogenesis and therapies: involvement of EGF-EGFR transduction system. Growth Factors 21:1–14
33. 33. KM Nicholson NG Anderson 2002 The protein kinase B/Akt signaling pathway in human malignancy Cell Signal 14 381 395 11882383 10.1016/S0898-6568(01)00271-6 1:CAS:528:DC%2BD38Xhs1ylsrs%3D Nicholson KM, Anderson NG (2002) The protein kinase B/Akt signaling pathway in human malignancy. Cell Signal 14:381–395
34. 34. MH Cardone N Roy HR Stennicke GS Salvesen TF Franke E Stanbridge S Frisch JC Reed 1999 Regulation of cell death protease caspase-9 by phosphorylation Science 282 1318 1321 10.1126/science.282.5392.1318 Cardone MH, Roy N, Stennicke HR, Salvesen GS, Franke TF, Stanbridge E, Frisch S, Reed JC (1999) Regulation of cell death protease caspase-9 by phosphorylation. Science 282:1318–1321
35. 35. A Brunet A Bonni MJ Zigmond MZ Lin P Juo LS Hu MJ Anderson KC Arden J Blenis ME Greenberg 1999 Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor Cell 96 857 868 10102273 10.1016/S0092-8674(00)80595-4 1:CAS:528:DyaK1MXitFGgsr0%3D Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J, Greenberg ME (1999) Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96:857–868
36. 36. JA Romashkova SS Makarov 1999 NF-κB is a target of Akt in anti-apoptotic PDGF signaling Nature 401 86 90 10485711 10.1038/43474 1:CAS:528:DyaK1MXlvVGmtr8%3D Romashkova JA, Makarov SS (1999) NF-κB is a target of Akt in anti-apoptotic PDGF signaling. Nature 401:86–90
37. 37. ON Ozes LD Mayo JA Gustin SR Pfeffer LM Pfeffer DB Donner 1999 NF-κB activation by tumor necrosis factor requires the Akt serine-threonine kinase Nature 401 82 85 10485710 10.1038/43466 1:CAS:528:DyaK1MXlvVGmsbY%3D Ozes ON, Mayo LD, Gustin JA, Pfeffer SR, Pfeffer LM, Donner DB (1999) NF-κB activation by tumor necrosis factor requires the Akt serine-threonine kinase. Nature 401:82–85
38. 38. GW Krystal G Sulanke J Litz 2002 Inhibition of phosphotidylinosital 3-kinase-Akt signaling blocks growth, promotes apoptosis, and enhances sensitivity of small cell lung cancer cells to chemotherapy Mol Cancer Ther 1 913 922 12481412 1:CAS:528:DC%2BD3sXmvFOnsw%3D%3D Krystal GW, Sulanke G, Litz J (2002) Inhibition of phosphotidylinosital 3-kinase-Akt signaling blocks growth, promotes apoptosis, and enhances sensitivity of small cell lung cancer cells to chemotherapy. Mol Cancer Ther 1:913–922
39. 39. Y Saito X Swanson AM Mhashikar Y Oida CD Branch S Chada L Zumstein Ramesh 2003 Adenovirus-mediated transfer of the PTEN gene inhibits human colorectal cancer growth in vitro and in vivo Gene Ther 10 1961 1969 14528320 10.1038/sj.gt.3302100 1:CAS:528:DC%2BD3sXnsl2rsLc%3D Saito Y, Swanson X, Mhashikar AM, Oida Y, Branch CD, Chada S, Zumstein L, Ramesh (2003) Adenovirus-mediated transfer of the PTEN gene inhibits human colorectal cancer growth in vitro and in vivo. Gene Ther 10:1961–1969
40. 40. X Liu Y Shi VL Giranda Y Luo 2006 Inhibition of the phosphotidylinositol 3-kinase/Akt pathway sensitizes MDA-MB468 human breast cancer cells to cerulenin-induced apoptosis Mol Cancer Ther 5 494 501 16546963 10.1158/1535-7163.MCT-05-0049 1:CAS:528:DC%2BD28Xitl2lsLo%3D Liu X, Shi Y, Giranda VL, Luo Y (2006) Inhibition of the phosphotidylinositol 3-kinase/Akt pathway sensitizes MDA-MB468 human breast cancer cells to cerulenin-induced apoptosis. Mol Cancer Ther 5:494–501
41. 41. JJ Raffoul Y Wang O Kucuk JD Forman FH Sarkar GG Hillman 2006 Genistein inhibits radiation-induced activation of NF-κB in prostate cancer cells promoting apoptosis and G2/M cell cycle arrest BMC Cancer 6 107 117 16640785 10.1186/1471-2407-6-107 1:CAS:528:DC%2BD28XkvV2qtrY%3D Raffoul JJ, Wang Y, Kucuk O, Forman JD, Sarkar FH, Hillman GG (2006) Genistein inhibits radiation-induced activation of NF-κB in prostate cancer cells promoting apoptosis and G2/M cell cycle arrest. BMC Cancer 6:107–117
42. 42. J Yao L Duan M Fan X Wu 2006 NF-κB signaling pathway is involved in growth inhibition, G2/M arrest and apoptosis induced by Trichostatin A in human tongue carcinoma cells Pharmacol Res 54 406 413 17005413 10.1016/j.phrs.2006.08.003 1:CAS:528:DC%2BD28XhtF2qu7jF Yao J, Duan L, Fan M, Wu X (2006) NF-κB signaling pathway is involved in growth inhibition, G2/M arrest and apoptosis induced by Trichostatin A in human tongue carcinoma cells. Pharmacol Res 54:406–413
43. 43. Y Saito X Swanson AM Mhashilkar Y Oida R Schrock CD Branch S Chada L Zumstein R Ramesh 2003 Adenovirus-mediated transfer of the PTEN gene inhibits human colorectal cancer growth in vitro and in vivo Gene Ther 10 1961 1969 14528320 10.1038/sj.gt.3302100 1:CAS:528:DC%2BD3sXnsl2rsLc%3D Saito Y, Swanson X, Mhashilkar AM, Oida Y, Schrock R, Branch CD, Chada S, Zumstein L, Ramesh R (2003) Adenovirus-mediated transfer of the PTEN gene inhibits human colorectal cancer growth in vitro and in vivo. Gene Ther 10:1961–1969
44. 44. K Selvendiran L Tong S Vishwanath A Bratasz NJ Trigg VK Kutala K Hideg P Kuppusamy 2007 EF24 induces G2/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by increasing PTEN expression J Biol Chem 282 28609 28618 17684018 10.1074/jbc.M703796200 1:CAS:528:DC%2BD2sXhtVOmtb3M Selvendiran K, Tong L, Vishwanath S, Bratasz A, Trigg NJ, Kutala VK, Hideg K, Kuppusamy P (2007) EF24 induces G2/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by increasing PTEN expression. J Biol Chem 282:28609–28618
45. 45. D Yin H Zhou T Kumagai G Liu JM Ong KL Black HP Koeffler 2005 Proteosome inhibitor PS-341 causes cell growth arrest and apoptosis in human glioblastoma multiforme (GBM) Oncogene 24 344 354 15531918 10.1038/sj.onc.1208225 1:CAS:528:DC%2BD2MXnsFSgtQ%3D%3D Yin D, Zhou H, Kumagai T, Liu G, Ong JM, Black KL, Koeffler HP (2005) Proteosome inhibitor PS-341 causes cell growth arrest and apoptosis in human glioblastoma multiforme (GBM). Oncogene 24:344–354
46. 46. GK Schwartz MA Shah 2005 Targeting the cell cycle: a new approach to cancer therapy J Clin Oncol 23 9408 9421 16361640 10.1200/JCO.2005.01.5594 1:CAS:528:DC%2BD28Xnt1ymtA%3D%3D Schwartz GK, Shah MA (2005) Targeting the cell cycle: a new approach to cancer therapy. J Clin Oncol 23:9408–9421
47. 47. I Budihardjo H Oliver M Lutter X Luo X Wang 1999 Biochemical pathways of caspase activation during apoptosis Ann Rev Cell Dev Biol 15 269 290 10.1146/annurev.cellbio.15.1.269 1:CAS:528:DC%2BD3cXhtVSnuro%3D Budihardjo I, Oliver H, Lutter M, Luo X, Wang X (1999) Biochemical pathways of caspase activation during apoptosis. Ann Rev Cell Dev Biol 15:269–290
48. 48. DM Finucane E Bossy-Wetzel NJ Waterhouse TG Cotter DR Green 1999 Bax-induced caspase activation and apoptosis via cytochrome c release from mitochondria is inhibitable by Bcl-xL J Biol Chem 274 2225 2233 9890985 10.1074/jbc.274.4.2225 1:CAS:528:DyaK1MXovVGmuw%3D%3D Finucane DM, Bossy-Wetzel E, Waterhouse NJ, Cotter TG, Green DR (1999) Bax-induced caspase activation and apoptosis via cytochrome c release from mitochondria is inhibitable by Bcl-xL. J Biol Chem 274:2225–2233
49. 49. Y Hu MA Benedict D Wu N Inohara G Nunez 1998 Bcl-xL interacts with Apaf-1 and inhibits Apaf-1-dependent caspase-9 activation Proc Natl Acad Sci USA 95 4386 4391 9539746 10.1073/pnas.95.8.4386 1:CAS:528:DyaK1cXis1Ohu74%3D Hu Y, Benedict MA, Wu D, Inohara N, Nunez G (1998) Bcl-xL interacts with Apaf-1 and inhibits Apaf-1-dependent caspase-9 activation. Proc Natl Acad Sci USA 95:4386–4391
50. 50. SN Willis JM Adams 2005 Life in the balance: how BH3-only proteins induce apoptosis Curr Opin Cell Biol 17 617 625 16243507 10.1016/j.ceb.2005.10.001 1:CAS:528:DC%2BD2MXhtFyksL%2FO Willis SN, Adams JM (2005) Life in the balance: how BH3-only proteins induce apoptosis. Curr Opin Cell Biol 17:617–625
51. 51. X Yan N Zhao C Yin Z Lu 1988 The effect of external Qi on liposome phase behavior Nat J 11 572 576 Yan X, Zhao N, Yin C, Lu Z (1988) The effect of external Qi on liposome phase behavior. Nat J 11:572–576
52. 52. C-C Yang H-P Lin C-S Chen Y-T Yang P-H Tseng VM Rangnekar C-S Chen 2003 Bcl-xL mediates a survival mechanism independent of the phosphoinositide 3-kinase/Akt pathway in prostate cancer cells J Biol Chem 278 25872 25878 12738789 10.1074/jbc.M301744200 1:CAS:528:DC%2BD3sXlt1ClsLk%3D Yang C-C, Lin H-P, Chen C-S, Yang Y-T, Tseng P-H, Rangnekar VM, Chen C-S. (2003) Bcl-xL mediates a survival mechanism independent of the phosphoinositide 3-kinase/Akt pathway in prostate cancer cells. J Biol Chem 278:25872–25878
53. 53. C Le Page IH Koumakpayi L Lessard F Saad AM Mes-Masson 2005 Independent role of phosphoinositol-3-kinase (PI3K) and casein kinase II (CK-2) in EGFR and Her-2-mediated constitutive NF-κB activation in prostate cancer cells Prostate 65 306 315 16015604 10.1002/pros.20291 1:CAS:528:DC%2BD28Xoslc%3D Le Page C, Koumakpayi IH, Lessard L, Saad F, Mes-Masson AM (2005) Independent role of phosphoinositol-3-kinase (PI3K) and casein kinase II (CK-2) in EGFR and Her-2-mediated constitutive NF-κB activation in prostate cancer cells. Prostate 65:306–315